4//SEC Filing
Zook Anthony P. 4
Accession 0001628280-25-038322
CIK 0001077183other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:07 PM ET
Size
10.9 KB
Accession
0001628280-25-038322
Insider Transaction Report
Form 4
Zook Anthony P.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-08-06$5.58/sh+17,900$99,954→ 38,066 total
Holdings
- 729,927
Stock Option (Right to Buy)
Exercise: $10.44Exp: 2035-04-01→ Common Stock (729,927 underlying) - 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 421,496
Restricted Stock Unit
Exercise: $0.00→ Common Stock (421,496 underlying) - 18,900(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
- [F2]On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F3]On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F4]Once vested, the shares of common stock are not subject to expiration.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001582393
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:07 PM ET
- Size
- 10.9 KB